Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution



Comments are closed.

Vium Expands Digital Vivarium Technology and Closes $24m Series B Financing
Hyperfine and Yale School of Medicine Collaborate on World’s First Portable MRI Technology
Keyssa on EE Times’ 60 Startups to Watch List
Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine